Category | Term | Count | p value |
---|---|---|---|
GOTERM_MF_5 | Zinc ion binding | 142 | 3.2E-16 |
GOTERM_CC_5 | Nucleus | 279 | 3.6E-12 |
GOTERM_BP_5 | Transcription | 128 | 2.5E-10 |
GOTERM_BP_5 | Regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolism | 121 | 5.5E-9 |
GOTERM_BP_5 | Cellular protein metabolism | 147 | 4.9E-8 |
GOTERM_MF_5 | Binding | 143 | 2.9E-7 |
GOTERM_MF_5 | Metal ion binding | 61 | 6.8E-7 |
GOTERM_MF_5 | Transition metal ion binding | 74 | 4.1E-6 |
GOTERM_MF_5 | Cation binding | 74 | 4.6E-6 |
GOTERM_MF_5 | Ion binding | 74 | 4.6E-6 |
GOTERM_BP_5 | Biopolymer modification | 83 | 1.3E-5 |
GOTERM_BP_5 | Response to unfolded protein | 12 | 2.5E-5 |
GOTERM_MF_5 | ATP binding | 84 | 6.8E-5 |
GOTERM_BP_5 | Apoptosis | 38 | 1.2E-4 |
GOTERM_CC_5 | Intracellular membrane-bound organelle | 225 | 2.4E-4 |
GOTERM_CC_5 | Membrane-bound organelle | 225 | 2.4E-4 |
GOTERM_BP_5 | Regulation of protein kinase activity | 12 | 3.1E-4 |
GOTERM_MF_5 | Protein kinase activity | 44 | 4.9E-4 |
KEGG_PATHWAY | MAPK signaling pathway | 24 | 7.1E-4 |
GOTERM_BP_5 | Nucleobase, nucleoside, nucleotide and nucleic acid metabolism | 18 | 1.7E-3 |
GOTERM_BP_5 | Regulation of programmed cell death | 24 | 1.9E-3 |
GOTERM_CC_5 | Intracellular | 244 | 3.3E-3 |
GOTERM_BP_5 | Response to protein stimulus | 6 | 3.4E-3 |
GOTERM_CC_5 | Vacuole | 17 | 3.4E-3 |
GOTERM_BP_5 | Phosphate metabolism | 45 | 3.7E-3 |
GOTERM_BP_5 | Cell death | 16 | 4.1E-3 |
GOTERM_BP_5 | Death | 16 | 4.1E-3 |
GOTERM_BP_5 | Programmed cell death | 16 | 4.1E-3 |
GOTERM_BP_5 | Negative regulation of cellular metabolism | 17 | 5.6E-3 |
BIOCARTA | The information-processing pathway at the IFN-β enhancer | 4 | 6.2E-3 |
GOTERM_BP_5 | Regulation of apoptosis | 22 | 6.7E-3 |
GOTERM_BP_5 | Protein kinase cascade | 17 | 6.8E-3 |
GOTERM_BP_5 | Embryonic development | 15 | 7.2E-3 |
GOTERM_MF_5 | Nucleotide binding | 41 | 8.9E-3 |
GOTERM_CC_5 | Intracellular organelle | 243 | 9.0E-3 |
GOTERM_CC_5 | Organelle | 243 | 9.0E-3 |
GOTERM_BP_5 | Negative regulation of progression through cell cycle | 10 | 9.3E-3 |
GOTERM_BP_5 | Regulation of progression through cell cycle | 24 | 9.7E-3 |
GOTERM_BP_5 | Positive regulation of programmed cell death | 12 | 1.2E-2 |
GOTERM_BP_5 | Embryonic limb morphogenesis | 7 | 1.5E-2 |
GOTERM_MF_5 | Pyrophosphatase activity | 29 | 2.1E-2 |
BIOCARTA | Regulation of transcriptional activity by PML | 4 | 2.2E-2 |
GOTERM_BP_5 | Cellular physiological process | 112 | 2.3E-2 |
GOTERM_MF_5 | Purine nucleotide binding | 52 | 2.4E-2 |
GOTERM_BP_5 | Embryonic development (sensu Mammalia) | 7 | 2.7E-2 |
GOTERM_CC_5 | Lytic vacuole | 13 | 2.8E-2 |
GOTERM_BP_5 | Negative regulation of protein kinase activity | 5 | 2.8E-2 |
GOTERM_BP_5 | Regulation of biological process | 34 | 2.9E-2 |
GOTERM_CC_5 | Cell | 256 | 3.0E-2 |
GOTERM_BP_5 | Regulation of cellular process | 29 | 3.4E-2 |
GOTERM_BP_5 | Regulation of protein biosynthesis | 9 | 3.8E-2 |
GOTERM_MF_5 | Transcription cofactor activity | 9 | 3.8E-2 |
GOTERM_MF_5 | Transcription factor binding | 9 | 4.0E-2 |
GOTERM_BP_5 | Negative regulation of programmed cell death | 9 | 4.2E-2 |
GOTERM_BP_5 | Protein catabolism | 13 | 4.2E-2 |
GOTERM_BP_5 | Regulation of gene expression, epigenetic | 3 | 4.2E-2 |
GOTERM_MF_5 | Protein kinase binding | 6 | 4.3E-2 |
GOTERM_BP_5 | Primary metabolism | 35 | 4.5E-2 |
GOTERM_BP_5 | RNA metabolism | 22 | 4.5E-2 |
GOTERM_BP_5 | Regulation of cellular biosynthesis | 9 | 4.7E-2 |
GOTERM_MF_5 | Guanyl nucleotide binding | 14 | 4.8E-2 |
GOTERM_BP_5 | Reproduction | 11 | 4.8E-2 |
GOTERM_BP_5 | Response to abiotic stimulus | 13 | 4.8E-2 |
GOTERM_BP_5 | Gene silencing | 4 | 5.0E-2 |
KEGG_PATHWAY | Pantothenate and CoA biosynthesis | 4 | 5.0E-2 |
GOTERM_BP_5 | Physiological process | 127 | 5.1E-2 |
GOTERM_BP_5 | Bone resorption | 3 | 5.2E-2 |
GOTERM_MF_5 | Cysteine-type peptidase activity | 9 | 5.2E-2 |
GOTERM_MF_5 | Ligase activity | 17 | 5.4E-2 |
GOTERM_BP_5 | Response to chemical stimulus | 11 | 5.4E-2 |
GOTERM_BP_5 | Regulation of bone remodeling | 4 | 5.6E-2 |
GOTERM_BP_5 | Biopolymer catabolism | 13 | 6.1E-2 |
KEGG_PATHWAY | Nitrogen metabolism | 4 | 6.3E-2 |
GOTERM_BP_5 | ER-nuclear signaling pathway | 3 | 6.4E-2 |
GOTERM_BP_5 | Regulation of protein metabolism | 13 | 6.4E-2 |
GOTERM_CC_5 | Nucleolus | 12 | 7.1E-2 |
GOTERM_BP_5 | Protein biosynthesis | 30 | 7.3E-2 |
GOTERM_MF_5 | Transcription corepressor activity | 6 | 7.3E-2 |
GOTERM_BP_5 | Intracellular receptor-mediated signaling pathway | 3 | 7.6E-2 |
GOTERM_MF_5 | Transcription regulator activity | 9 | 7.7E-2 |
GOTERM_BP_5 | Macromolecule biosynthesis | 33 | 8.0E-2 |
GOTERM_BP_5 | Positive regulation of cell proliferation | 9 | 8.1E-2 |
GOTERM_BP_5 | Embryonic hemopoiesis | 2 | 8.2E-2 |
GOTERM_BP_5 | Posttranscriptional gene silencing | 2 | 8.2E-2 |
GOTERM_BP_5 | RNA-mediated gene silencing | 2 | 8.2E-2 |
GOTERM_BP_5 | RNA-mediated posttranscriptional gene silencing | 2 | 8.2E-2 |
GOTERM_MF_5 | Glutaminase activity | 2 | 8.4E-2 |
GOTERM_MF_5 | Ubiquitin-protein ligase activity | 16 | 8.4E-2 |
GOTERM_BP_5 | Eye development | 5 | 8.6E-2 |
BIOCARTA | Eukaryotic protein translation | 3 | 9.0E-2 |
GOTERM_BP_5 | Amino acid transport | 6 | 9.1E-2 |
GOTERM_BP_5 | Positive regulation of cell activation | 5 | 9.2E-2 |
GOTERM_BP_5 | Development | 37 | 9.3E-2 |